Literature DB >> 7672786

Desmin myopathy: a multisystem disorder involving skeletal, cardiac, and smooth muscle.

A Ariza1, J Coll, M T Fernández-Figueras, M D López, J L Mate, O García, A Fernández-Vasalo, J J Navas-Palacios.   

Abstract

Myopathy associated with desmin-type intermediate filaments is an uncommon disorder of skeletal and/or cardiac muscle. The present study focuses on a 28-year-old man with generalized muscular atrophy, cardiomyopathy, and intestinal malabsorption and pseudo-obstruction. Abundant sarcoplasmic granular and filamentous aggregates that were ultrastructurally continuous with Z lines or dense bodies and exhibited intense immunostaining for desmin were present throughout the skeletal musculature, myocardium, and smooth muscle of the intestine. Moreover, neurofilament-immunoreactive axonal spheroids were identified in the spinal cord and roots. These widely distributed findings illustrate the multisystemic character of desmin myopathy, which in this instance first adds intestinal smooth muscle involvement to its already known skeletal and cardiac muscle manifestations. The additional presence of neurofilament aggregates in the spinal cord and roots constitutes an extremely rare conjunction of intermediate filament pathology of the neuromuscular system.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7672786     DOI: 10.1016/0046-8177(95)90095-0

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  16 in total

1.  Lower active force generation and improved fatigue resistance in skeletal muscle from desmin deficient mice.

Authors:  J Balogh; Z Li; D Paulin; A Arner
Journal:  J Muscle Res Cell Motil       Date:  2003       Impact factor: 2.698

Review 2.  Desmin cytoskeleton in healthy and failing heart.

Authors:  Y Capetanaki
Journal:  Heart Fail Rev       Date:  2000-10       Impact factor: 4.214

3.  Recessive DES cardio/myopathy without myofibrillar aggregates: intronic splice variant silences one allele leaving only missense L190P-desmin.

Authors:  Lisa G Riley; Leigh B Waddell; Roula Ghaoui; Frances J Evesson; Beryl B Cummings; Samantha J Bryen; Himanshu Joshi; Min-Xia Wang; Susan Brammah; Leonard Kritharides; Alastair Corbett; Daniel G MacArthur; Sandra T Cooper
Journal:  Eur J Hum Genet       Date:  2019-04-25       Impact factor: 4.246

4.  A dysfunctional desmin mutation in a patient with severe generalized myopathy.

Authors:  A M Muñoz-Mármol; G Strasser; M Isamat; P A Coulombe; Y Yang; X Roca; E Vela; J L Mate; J Coll; M T Fernández-Figueras; J J Navas-Palacios; A Ariza; E Fuchs
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-15       Impact factor: 11.205

5.  Distribution and organization of desmin in cultured adult cardiac muscle cells: reflection on function.

Authors:  A C Nag; S K Huffaker
Journal:  J Muscle Res Cell Motil       Date:  1998-11       Impact factor: 2.698

6.  Intermediate filament diseases: desminopathy.

Authors:  Lev G Goldfarb; Montse Olivé; Patrick Vicart; Hans H Goebel
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

7.  Severe infantile-onset cardiomyopathy associated with a homozygous deletion in desmin.

Authors:  Gerard Piñol-Ripoll; Alexey Shatunov; Ana Cabello; Pilar Larrodé; Iris de la Puerta; Juana Pelegrín; Feliciano J Ramos; Montse Olivé; Lev G Goldfarb
Journal:  Neuromuscul Disord       Date:  2009-05-09       Impact factor: 4.296

Review 8.  Tragedy in a heartbeat: malfunctioning desmin causes skeletal and cardiac muscle disease.

Authors:  Lev G Goldfarb; Marinos C Dalakas
Journal:  J Clin Invest       Date:  2009-07-01       Impact factor: 14.808

9.  Desmin filaments influence myofilament spacing and lateral compliance of slow skeletal muscle fibers.

Authors:  J Balogh; Z Li; D Paulin; A Arner
Journal:  Biophys J       Date:  2004-11-12       Impact factor: 4.033

Review 10.  Desminopathies: pathology and mechanisms.

Authors:  Christoph S Clemen; Harald Herrmann; Sergei V Strelkov; Rolf Schröder
Journal:  Acta Neuropathol       Date:  2012-11-11       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.